Pfizer Inc. (PFE) — closed signal from September 7, 2025
Partial Published before the outcome was known, scored automatically when the window closed on December 6, 2025.
Predicted vs. what happened
What happened
Reached 66% of the predicted growth at its peak, without hitting the target.
The thesis — published September 7, 2025
Pfizer's price has fallen a lot, which can set up a short-term bounce. Investors seem more optimistic than the drop suggests, and recent news in the sector wasn't about Pfizer itself. Our usual trend check still looks weak, so we'd buy in small steps and keep risk small. Over the next few months, a modest rebound is reasonable as income-focused buyers like the dividend, safer stocks come back into favor, and the recent average price starts to steady.
Primary drivers
- Price is depressed, which often leads to a bounce as sellers run out of steam.
- Optimistic mood contrasts with the weak price, hinting at a possible rebound.
- Solid dividend and a safer profile can attract steady, income-seeking buyers.
- Recent average price is beginning to calm, a sign selling pressure may ease.
How it played out
PFE: rebound came through, but the target was missed
Lyra published PFE at 24.45 on 2025-09-07 with a short-term rebound thesis. It expected 17% growth toward 28.11. The thesis pointed to a depressed price, a more optimistic mood than the chart showed, dividend appeal for income-focused buyers, and a recent average price that had begun to calm.
Inside the window, PFE rose to 27.21 on 2025-10-03, with a peak gain of 11.3%. It never reached 28.11. By 2025-12-06, it ended at 26.03. The direction matched the published rebound call, but the target was missed. Verdict: partial play-out.
What happened during the window
On 2025-09-22, Pfizer announced a deal to acquire Metsera, according to MarketWatch. On 2025-10-30, The Guardian reported that Novo Nordisk made a competing bid for Metsera, challenging Pfizer's agreed deal.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.